Arformoterol
Arformoterol
Arformoterol (pronounced: ar-for-MOH-ter-ol) is a long-acting beta2-adrenergic agonist drug that is used in the treatment of chronic obstructive pulmonary disease (COPD). It is marketed under the brand name Brovana.
Etymology
The name "Arformoterol" is derived from the chemical structure of the drug, which is an R,R-enantiomer of formoterol. The prefix "ar" is derived from "aristero", a Greek word meaning "best", indicating that arformoterol is the more effective enantiomer of formoterol.
Pharmacology
Arformoterol works by relaxing and opening the air passages to the lungs, making it easier to breathe. It is a bronchodilator, which means it expands the bronchi and bronchioles in the lungs. It is used to prevent bronchospasm in people with COPD, including chronic bronchitis and emphysema.
Related Terms
- Beta2-adrenergic agonist: A class of drugs that are used to treat asthma and COPD. They work by relaxing the muscles in the airways and increasing airflow to the lungs.
- Bronchodilator: A type of medication that makes breathing easier by relaxing the muscles in the lungs and widening the bronchi.
- Bronchospasm: A sudden constriction of the muscles in the walls of the bronchioles.
- Chronic Obstructive Pulmonary Disease (COPD): A type of obstructive lung disease characterized by long-term breathing problems and poor airflow.
- Formoterol: A long-acting beta2 agonist (LABA) used in the management of asthma and COPD.
External links
- Medical encyclopedia article on Arformoterol
- Wikipedia's article - Arformoterol
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski